Neon Therapeutics Inc (NTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 29,395 | 52,700 | 58,250 | 88,493 |
| Marketable Securities | N/A | 50,611 | 21,475 | N/A |
| TOTAL | $31,243 | $105,427 | $81,306 | $89,531 |
| Non-Current Assets | ||||
| PPE Net | 7,109 | 8,205 | 6,888 | 4,231 |
| Other Non-Current Assets | 8,020 | 456 | 2,299 | 1,499 |
| TOTAL | $15,129 | $8,661 | $9,187 | $5,730 |
| Total Assets | $46,372 | $114,088 | $90,493 | $95,261 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 1,702 | 4,268 | 2,166 | 3,207 |
| Accrued Expenses | 7,464 | 8,422 | 6,601 | 1,503 |
| TOTAL | $10,407 | $12,690 | $8,767 | $4,710 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 6,548 | 149 | 175,298 | 129,043 |
| TOTAL | $6,548 | $149 | $175,298 | $129,043 |
| Total Liabilities | $16,955 | $12,839 | $184,065 | $133,753 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 28,858 | 28,331 | N/A | N/A |
| Common Shares | 29 | 28 | 3 | 3 |
| Retained earnings | -253,538 | -173,762 | -93,562 | -38,495 |
| Other shareholders' equity | 0 | -75 | -13 | 0 |
| TOTAL | $29,417 | $101,249 | $-93,572 | $-38,492 |
| Total Liabilities And Equity | $46,372 | $114,088 | $90,493 | $95,261 |